* Japanese*
Asahikawa Medical College , Faculty of Medicine
2001.03 , Graduated
Asahikawa Medical College , Graduate School, Division of Medicine
Doctor Course , 2006.03 , Completed
Duty , Asahikawa Medical University School of Medicine Medical Course Basic Medicine Pathology[Immuno Pathology] , Lecturer , 2019.04 -
Duty , Asahikawa Medical University School of Medicine Medical Course Clinical Medicine Otorhinolaryngology,Head and Neck Surgery , Assistant Professor , 2010.04 - 2019.03
Otorhinolaryngology
Experimental pathology
Human pathology
English: Kono M, Wakisaka R, Komatsuda H, Hayashi R, Kumai T, Yamaki H, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Kobayashi H, Hayashi T, Takahara M., Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer. , Head & Neck , vol.Online ahead of print. , 2024 , (IF:2.9)
English: Murai A, Kubo T, Ohkuri T, Yanagawa J, Yajima Y, Kosaka A, Li D, Nagato T, Murata K, Kanaseki T, Tsukahara T, Nagasaki T, Hirohashi Y, Kobayashi H, Torigoe T., NF9 peptide specific cytotoxic T lymphocyte clone cross react to Y453F mutation of SARS-CoV-2 virus spike protein. , Immunological Medicine , vol.Online ahead of print. , 2024 , (IF:4.4)
English: Nagato T, Komatsuda H, Hayashi R, Takahara M, Ujiie N, Kosaka A, Ohkuri T, Oikawa K, Sato R, Wakisaka R, Kono M, Yamaki H, Ohara K, Kumai T, Kishibe K, Katada A, Hayashi T, Kobayashi H., Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma. , Cancer Science , vol.Online ahead of print. , 2024 , (IF:5.7)
English: Yajima Y, Kosaka A, Ohkuri T, Hirohashi Y, Li D, Nagasaki T, Nagato T, Torigoe T, Kobayashi H., SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity. , Heliyon , vol.9 (9) (p.e20192 - ) , 2023 , (IF:4)
English: Yamaki H, Kono M, Wakisaka R, Komatsuda H, Kumai T, Hayashi R, Sato R, Nagato T, Ohkuri T, Kosaka A, Ohara K, Kishibe K, Takahara M, Hayashi T, Kobayashi H, Katada A., Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer. , Cancer Immunology, Immunotherapy , vol.72 (8) (p.2799 - 2812) , 2023 , (IF:6.630)
English: Takahara M, Kumai T, Kishibe K, Nagato T, Harabuchi Y., Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein-Barr Virus Relation. , MDPI , Microorganisms , vol.9 (7) (p.1381 - ) , 2021 , (IF:4.128)
English: Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T., Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress. , Frontiers , Frontiers in Pediatrics , vol.7 (p.141 - ) , 2019 , (IF:2.335)
English: Ohkuri T, Kosaka A, Nagato T, Kobayashi H., Effects of STING stimulation on macrophages: STING agonists polarize into "classically" or "alternatively" activated macrophages? , Taylor & Francis , Human Vaccines & Immunotherapeutics , vol.14 (2) (p.285 - 287) , 2018 , (IF:2.157)
English: Nagato T, Celis E., A novel combinatorial cancer immunotherapy: poly-IC and blockade of the PD-1/PD-L1 pathway. , Taylor & Francis , Oncoimmunology , vol.3 (p.e28440 - ) , 2014 , (IF:6.283)
English: Harabuchi Y, Takahara M, Kishibe K, Moriai S, Nagato T, Ishii H., Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features. , Springer , International Journal of Clinical Oncology , vol.14 (3) (p.181 - 190) , 2009 , (IF:1.727)
The International Conference: 18th International Conference on EBV & KSHV , 2018.07 - 2018.08
The International Conference: 17th international symposium on EBV and associated diseases , 2016.08
The International Conference: 16th international symposium on EBV and associated diseases , 2014.07
Updated on 2024/09/13
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.
